RaminFarzaneh-FarMD
Cardiology • Dallas, TXAdult Congenital Heart Disease
Assistant Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School
Are you Dr. Farzaneh-Far?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 43 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Ut Southwestern Medical Ctr
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-7500- Is this information wrong?
Summary
- Dr. Ramin Farzaneh-Far, MD is a cardiologist in Dallas, Texas. He is currently licensed to practice medicine in Texas and California. He is an Assistant Professor at University of Texas Southwestern Medical Center.
Education & Training
University of California (San Francisco)Fellowship, Cardiovascular Disease, 2006 - 2009
Brigham and Women's HospitalResidency, Internal Medicine, 2003 - 2005
Royal Free Hospital and University College London Medical SchoolClass of 2002
Certifications & Licensure
CA State Medical License 2006 - 2026
TX State Medical License 2011 - 2014
Clinical Trials
- Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease Start of enrollment: 2015 Dec 01
- Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) Start of enrollment: 2016 Feb 01
Publications & Presentations
PubMed
- 2 citationsPhase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria.Austin G Kulasekararaj, Anna-Elina Lehtinen, Cecily Forsyth, Shreyans Gandhi, Morag Griffin, Sixten Körper, Gabor Mikala, Petra Muus, Ulrik Overgaard, Christopher J Pa...> ;Haematologica. 2024 Mar 1
- 26 citationsZilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody-Positive Generalized Myasthenia Gravis.James F. Howard, John Vissing, Nils Erik Gilhus, Maria Isabel Leite, Kimiaki Utsugisawa, Duda Petra, Farzaneh-Far Ramin, Hiroyuki Murai, Heinz Wiendl> ;Expert Opinion on Investigational Drugs. 2021 Apr 1
- 102 citationsBody mass index is negatively associated with telomere length : a collaborative cross-sectional meta-analysis of 87 observational studiesMarij Gielen, Geja J. Hageman, Evangelia Antoniou, Katarina Nordfjäll, Massimo Mangino, Muthuswamy Balasubramanyam, Tim De Meyer, Audrey E. Hendricks, Erik J. Giltay, ...> ;The American Journal of Clinical Nutrition. 2018 Sep 30
- Join now to see all
Press Mentions
Ra Pharmaceuticals Reports Second Quarter 2018 Financial Results and Announces Early Completion of Enrollment in gMG Phase 2 ProgramAugust 8th, 2018
Ra Pharmaceuticals Initiates Phase 1b Trial of New Therapy for Lupus NephritisJanuary 9th, 2018
